Marin-Garcia J, Ananthakrishnan R, Goldenthal M J, Filiano J J, Perez-Atayde A
The Molecular Cardiology Institute, Highland Park, New Jersey 08904, USA.
Pediatrics. 1999 Feb;103(2):456-9. doi: 10.1542/peds.103.2.456.
This study sought to examine skeletal muscle of children with cardiomyopathy (CM) for changes in mitochondrial enzyme activities and in mitochondrial DNA (mtDNA).
Heart mitochondrial enzymatic activity defects have been often found in dilated and hypertrophic CM. The defects primarily involve the activities of the electron transport system and oxidative phosphorylation pathway including respiratory complexes I, III, IV, and V.
Skeletal muscle biopsies of 8 children with CM were examined for specific mitochondrial enzyme activities, mtDNA copy number and the presence of pathogenic mutations and deletions in mtDNA.
A marked deficiency in specific mitochondrial enzyme activities was found in 6 of 8 patients in skeletal muscle as well as in 2 of 3 hearts of those in whom cardiac tissue was available. Specific activity defects were found in complex I (2 cases), complex III (5 cases), complex IV (3 cases), and complex V (4 cases). Complex II and citrate synthase activities were unaffected. None of the previously reported pathogenic mutations associated with CM were detected, nor was there any evidence of mtDNA depletion. The incidence of defective respiratory complex activities in skeletal muscle was similar to the incidence of defective complex activities previously reported in cardiac tissue.
Mitochondrial analysis of skeletal muscle is warranted in the overall clinical evaluation of children with CM, and particularly before consideration for cardiac transplantation.
本研究旨在检查心肌病(CM)患儿的骨骼肌,以观察线粒体酶活性和线粒体DNA(mtDNA)的变化。
在扩张型和肥厚型CM中常发现心脏线粒体酶活性缺陷。这些缺陷主要涉及电子传递系统和氧化磷酸化途径的活性,包括呼吸复合体I、III、IV和V。
对8例CM患儿的骨骼肌活检样本进行特定线粒体酶活性、mtDNA拷贝数以及mtDNA致病突变和缺失情况的检测。
8例患者中有6例骨骼肌以及3例有心脏组织可供检测的患者中的2例心脏,出现了特定线粒体酶活性的显著缺乏。在复合体I(2例)、复合体III(5例)、复合体IV(3例)和复合体V(4例)中发现了特定活性缺陷。复合体II和柠檬酸合酶活性未受影响。未检测到先前报道的与CM相关的致病突变,也没有mtDNA耗竭的证据。骨骼肌中呼吸复合体活性缺陷的发生率与先前报道的心脏组织中复合体活性缺陷的发生率相似。
在CM患儿的全面临床评估中,尤其是在考虑心脏移植之前,对骨骼肌进行线粒体分析是必要的。